UCSF’s Henry Bourne has an interesting piece out in PNAS about the boom/bust cycle in biomedical research and specifically how the most recent version played out with vast over-building of infrastructure combined with a shift to soft-money support for PI’s. The documentation of the problems is very impressive, however the notion that this can be fixed piecemeal at a few “pioneer” research institutions I think is dead wrong. To my mind, such elitism is exactly how we arrived at our current situation. And in fact, I’m pleased to report that it’s actually at non-elite institutions where the hard money regime still exists, supported by tuition and, in the case of publics, some state support.
Do I have a solution? Here’s a possibility: I urge my biomedical colleagues to take a hard look at the decadal surveys of other fields (e.g. astronomy or oceanography) where hard prioritization choices are made nationally on the basis of evidence.